| Financial Year |
March 31 2023 |
| Monetary Funds |
1,077,909,000.63 |
| Held-for-trading Financial Assets |
105,000,000.00 |
| Notes Receivable |
217,377,938.64 |
| Accounts Receivable |
926,304,050.81 |
| Advances to Suppliers |
89,073,409.26 |
| Other Receivables |
44,133,980.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,532,373,772.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
55,889,084.59 |
| Total Current Assets |
4,275,145,889.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,100,318.28 |
| Fixed Assetes |
266,071,303.56 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,750,090.49 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
38,238,766.02 |
| Deferred Income Tax Assets |
36,593,589.94 |
| Other Non-Current Assets |
102,248,224.36 |
| Sub-Total of Non-Current Assets |
485,590,266.20 |
| Total Assets |
4,760,736,155.97 |
| Short-Term Loans |
286,211,393.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,331,220,900.55 |
| Accounts Payable |
1,127,403,558.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,770,542.56 |
| Taxes Payable |
4,024,807.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
133,180.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,694,943.68 |
| Other Current Liabilities |
90,125,404.27 |
| Sub-Total of Current Liabilities |
3,158,836,098.04 |
| Long-term Loans |
115,750,000.00 |
| Bonds Payable |
372,925,837.49 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,021,887.34 |
| Deferred Income Tax Liabilities |
737,325.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
523,773,929.34 |
| Total Liabilities |
3,682,610,027.38 |
| Paid-In Capital(Or Share Stock) |
237,610,488.00 |
| Capital Surplus |
324,482,145.44 |
| Surplus Reserve |
42,549,076.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
423,577,873.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,078,126,128.59 |
| Owner's Equity（Stockholder's Equity） |
1,078,126,128.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,760,736,155.97 |
